AI Guidance in Oncology

Healio has announced its intention to launch OncoIntel, a new platform designed to deliver AI Guidance in Oncology by integrating expert-led content with generative AI technology. Developed in collaboration with a major cancer research institution, the tool is intended to support oncology healthcare professionals (HCPs) with real-time access to curated updates, video commentary, clinical data, and automated responses to practice-based queries. 

Scheduled for release in fall 2025, OncoIntel combines traditional medical reporting with AI-enhanced functionality through its Smart Guidance assistant. This feature is designed to deliver daily updates drawn from peer-reviewed studies, clinical trials, and breaking news, offering immediate responses to oncology-specific clinical questions. Healio reports that Smart Guidance is currently undergoing testing by oncology professionals to assess its accuracy and usability. AI Guidance in Oncology is emerging as a key support mechanism for clinicians navigating complex and rapidly evolving cancer care pathways.

While the tool will initially focus on cancer care, Healio has indicated plans to extend its AI-guided approach to additional therapeutic areas beginning in 2026. 

Implications for media professionals 

The rise of AI guidance in oncology reflects broader shifts in how clinicians access and apply information in practice. For pharma marketers, this may require rethinking how content is developed and delivered. As AI-assisted tools...